- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02696317
Clinical Evaluation of ACUVUE® OASYS® 1-Day and ACUVUE® OASYS®
May 31, 2018 updated by: Alcon Research
Clinical Evaluation of ACUVUE® OASYS® 1-Day Daily Disposable Silicone Hydrogel Contact Lenses
The purpose of this study is to evaluate the performance of two commercially-available silicone hydrogel contact lenses in normal and low humidity environments after at least 7 days of wear.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
After randomization to lens order, subjects attended study visits that included a 3 hour exposure to reduced humidity environment (20% relative humidity) and subsequent tear film assessments for each study lens.
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must sign an informed consent form;
- Adapted, current soft silicone hydrogel daily disposable contact lens wearer during the last 2 months;
- Prescription within power range of both study contact lenses, as stated in the protocol;
- Cylinder equal or lower than -0.75 diopter (D) in both eyes;
- Willing to wear lenses every day or at least a minimum of 5 days per week, 6 hours per day;
- Willing to discontinue artificial tears and rewetting drops on the days of study visits;
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
- Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
- Monocular (only 1 eye with functional vision) or fit with only 1 lens;
- History of herpetic keratitis, ocular surgery, or irregular cornea;
- Pregnant or lactating;
- Current AO1D or AO lens wearer;
- Other protocol-specified exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: AO1D, then AO
Senofilcon A contact lenses with HydraLuxe™, followed by senofilcon A contact lenses.
Each product worn bilaterally (in both eyes) for 10 days in a daily wear, daily disposable modality.
|
Contact lenses worn during Period 1 or 2, as randomized
Other Names:
Contact lenses worn during Period 1 or 2, as randomized
Other Names:
|
|
Other: AO, then AO1D
Senofilcon A contact lenses, followed by senofilcon A contact lenses with HydraLuxe™.
Each product worn bilaterally for 10 days in a daily wear, daily disposable modality.
|
Contact lenses worn during Period 1 or 2, as randomized
Other Names:
Contact lenses worn during Period 1 or 2, as randomized
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tear Film Evaporation Rate in a Normal Environment After 10 ± 3 Days of Wear (Pre RH)
Time Frame: Day 10 ± 3 days, each product
|
Tear film evaporation rate (amount of tears that evaporates over a surface area per seconds) assessment was performed using the Oregon Health Sciences University Evaporometer.
Measurements were taken on both the right and left eyes after 3 hours of wear in a normal environment after 10 ± 3 days of lens wear.
The temperature and humidity were measured within an air chamber around the ocular surface with the eyes opened and closed.
The evaporation from the ocular surface was calculated as the difference between the evaporation rate of the skin taken during the closed eye measurement and the evaporation rate taken during the open eye measurement.
The rate of evaporation was measured in g/cm2/sec for 2 humidity ranges.
A higher evaporation rate can be a contributing factor to eye irritation and lens intolerance.
|
Day 10 ± 3 days, each product
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tear Film Evaporation Rate After 10 ± 3 Days of Wear and After 3 Hours Exposure to Reduced Humidity (Post RH)
Time Frame: Day 10 ± 3 days, each product
|
Tear film evaporation rate (amount of tears that evaporates over a surface area per seconds) assessment was performed using the Oregon Health Sciences University Evaporometer.
Measurements were taken on both the right and left eyes after 6 hours of lens wear, including 3 hours of wear in a 20% reduced humidity environment (20% RH), after 10 ± 3 days of lens wear.
The temperature and humidity were measured within an air chamber around the ocular surface with the eyes opened and closed.
The evaporation from the ocular surface was calculated as the difference between the evaporation rate of the skin taken during the closed eye measurement and the evaporation rate taken during the open eye measurement.
The rate of evaporation was measured in g/cm2/sec for 2 humidity ranges.
A higher evaporation rate can be a contributing factor to eye irritation and lens intolerance.
|
Day 10 ± 3 days, each product
|
|
Pre-Lens Tear Film Minimum Protected Area (MPA) in a Normal Environment After 10 ± 3 Days of Wear (Pre RH)
Time Frame: Day 10 ± 3 days, each product
|
MPA is the minimum area of the contact lens surface (expressed in %) that is protected by the tear film during the entire interblink period.
Pre-lens tear film MPA was assessed in a normal environment following 3 hours of wear.
Higher values indicate less dry and more eye comfort.
|
Day 10 ± 3 days, each product
|
|
Pre-Lens Tear Film MPA After 10 ± 3 Days of Wear and After 3 Hours Exposure to Reduced Humidity (Post RH)
Time Frame: Day 10 ± 3 days, each product
|
MPA is the minimum area of the contact lens surface (expressed in %) that is protected by the tear film during the entire interblink period.
Pre-lens tear film MPA was assessed following 6 hours of wear including 3 hours in a reduced humidity environment (20% RH).. Higher values indicate less dry and more eye comfort.
|
Day 10 ± 3 days, each product
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Senior Clinical Manager, GCRA Operations, Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 18, 2016
Primary Completion (Actual)
June 6, 2016
Study Completion (Actual)
June 6, 2016
Study Registration Dates
First Submitted
February 24, 2016
First Submitted That Met QC Criteria
February 26, 2016
First Posted (Estimate)
March 2, 2016
Study Record Updates
Last Update Posted (Actual)
July 2, 2018
Last Update Submitted That Met QC Criteria
May 31, 2018
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLE198-P001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Myoptechs, IncUniversity of Waterloo School of Optometry and Vision ScienceNot yet recruitingMyopia: Refractive Error
-
Perfect Lens, LLCCompletedRefractive Error CorrectionPanama
-
Essilor InternationalRecruitingRefractive Error | AmetropiaUnited States
Clinical Trials on Senofilcon A contact lenses with HydraLuxe™
-
Alcon, a Novartis CompanyCompleted
-
Alcon ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedMyopia | AmetropiaUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States